研究突显了青春期阻塞剂和针对有性病的青年的荷尔蒙疗法的不确定性,要求改进研究。 Studies highlight uncertainties over puberty blockers and hormone therapy for gender-dysphoric youth, calling for better research.

最近的研究突出表明,青春期阻塞症和确认性别的荷尔蒙疗法对患有性别残疾的儿童的影响有很大的不确定性,这与希拉里·卡斯审查所表示的关切是一致的。 Recent studies highlight significant uncertainties about the impact of puberty blockers and gender-affirming hormone therapy on children with gender dysphoria, echoing concerns from the Hilary Cass review. 研究人员呼吁进行更好、更严格的研究,以改进这些治疗的证据基础,因为目前的数据不足以确定它们的安全和有效性。 Researchers call for better, more rigorous studies to improve the evidence base for these treatments, as current data is inadequate to determine their safety and effectiveness. 这种不确定性正在激起目前关于青年人使用这些药物的辩论。 This uncertainty is fueling ongoing debates about their use in young people.